Asure Software

ASUR · NASDAQ

$7.13+$0.09 (+1.28%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $7.04

ASUR analyst rating

BuyConsensus of 2 analysts over the last 12 months. 100% rate it a buy.

Strong buy0
Buy2
Hold0
Underperform0
Sell0

12-month price target · 11 analysts

Average $13.37 (+87.6% upside)

Low: $11.11
Now: $7.13
High: $15.75

Upgrades and downgrades

The latest rating actions, newest first

ASUR analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Barrington Research	Apr 24, 2026	Maintains	Outperform	$15.00	50%
Barrington Research	Feb 20, 2026	Maintains	Outperform	$15.00	50%
Barrington Research	Dec 9, 2025	Maintains	Outperform	$15.00	50%
Freedom Broker	Nov 21, 2025	Maintains	Buy	$14.50 → $13.00	42%
Barrington Research	Nov 3, 2025	Maintains	Outperform	$15.00	50%
Barrington Research	Oct 23, 2025	Maintains	Outperform	$15.00	50%

The case for and against

Updated Apr 17, 2026

Bull case

Asure Software Inc. demonstrated a strong performance with total revenue increasing by 28% year-over-year (YOY) when excluding the impact of the Employee Retention Tax Credit (ERTC) program, along with a healthy 7% YOY organic growth. Additionally, the company's adjusted Q3/25 bookings, discounting enterprise deals, rose by 21% YOY, highlighting robust demand for its cloud-based Human Capital Management solutions. Furthermore, cross-selling revenue also exhibited positive movement, increasing by 7% sequentially, underscoring the effectiveness of Asure's sales strategies in enhancing customer engagement and revenue streams.

Bear case

Asure Software Inc. experienced a significant decline in its adjusted gross margin, falling from 73.0% year-over-year to 70.1% in Q3/25, primarily attributed to the acquisition of Lathem, which contributed lower gross margins compared to Asure's previous core business. Additionally, the company reported a notable decrease of 41% in bookings year-over-year, which reflects challenges in securing large enterprise deals that had bolstered performance in the prior year. Despite beating revenue and adjusted EBITDA forecasts in Q3/25, Asure's non-GAAP EPS of $0.15 missed both internal and consensus expectations due to elevated interest expenses and a higher tax rate, positioning the company at a substantial 64% valuation discount relative to its peer group.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.